Vaccine Market - By Technology & Types, Trend Analysis By Various Classes - Live / Attenuated, Subunit, Toxoid, Conjugate, DNA, Recombinant Vector, Synthetic, Dentritic Vaccines And By Indications - Infectious Diseases, Cancer, Allergy, Diabetes, Cardiovascular Disease With Market Landscape Analysis - Global Forecasts To 2022 On 20th June 2014
The vaccine market is an established segment and is widely accepted as an indispensable division of the healthcare industry. It is poised to grow rapidly by addressing the following: emerging infectious agents, various types of cancer, allergies, cardiovascular diseases, diabetes, smoke cessation, and neurodegenerative disorders. The global vaccine market is estimated at $32.05 billion in 2013 and is expected to reach $84.44 billion by 2022. Browse Full Report @ http://www.jsbmarketresearch.com/healthcare-medical/r-VaccineMarket-By-Technology-Types-Trend-Analysis-By-Various-Classes-Global-Forecasts-114172 In general, the vaccine market is largely perceived negatively as a low-profit venture owing to the domination of top five companies, namely, Sanofi (France), Glaxo Smithkline (U.K.), Merck (U.S.), Pfizer (U.S.), and Novartis (Switzerland). Furthermore, a strong patent portfolio and the need for large investments towards vaccine development have limited the scope of entry for new companies. The vaccine market is analyzed both in terms of qualitative (technological) and quantitative (revenue) perspectives. The technological analysis includes a discussion on different classes of vaccines, vaccine adjuvants, and commercially available products. The market revenue analysis includes market segmentation and the expected market position by 2022, with the projected growth rate. The vaccine market is classified by technology class, types, end users, disease indication, and geography. The details on the emerging approaches to vaccine development such as reverse Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
vaccinology, personalized vaccinomics, and systems vaccinomics are discussed. Furthermore, key research centers, with their critical areas of research in the vaccine space, have been provided. An overview of regulations across various geographical regions has been covered. The complete value chain of the vaccine market is schematically represented and the significance of each stakeholder has been briefed. Apart from the technological and market analysis, the investor climate has been assessed by tracking the complete investor network and collecting data on funds/grants and investments made towards vaccine development. Insights on current and future technological investment trends have also been discussed. A large number of potential therapeutic and preventive vaccine candidates addressing various diseases which are in the pipeline are listed with their current status in clinical trials. The adoption and developmental potential of the vaccine technology market has been discussed on a geographic basis, namely, North America, Europe, Asia, and the Rest of the World, by taking select countries that are poised to have a greater market value during the forecast period. In brief, this research report provides: A detailed description of the global technology developments and evolving trends in the vaccine field with key prominence on research innovations, collaborative efforts, and investments for vaccines. A close view on the therapeutic vaccines for various diseases by providing details and status of current vaccines in the pipeline. An impact analysis of the major drivers and restraints influencing the adoption and growth of the vaccine market during the period of 2013 to 2022. Porters five forces analysis and GAP analysis. The global market forecast for 2013 - 2022, including demand side analysis and strategic recommendations for technology/product developers. Competitive landscape tracking industry activities such as mergers, acquisitions, partnerships, collaborations, and strategic agreements within the vaccine market. Intellectual property strength analysis based on the number of patents filed by the top five players within the vaccine market that gives an insight into prominent activities and global leaders of the industry. Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Scope of the Report This research report categorizes the global vaccine market into technology class, types, end users, disease indication, and geography. Each segment is further broken down by geography, with exhaustive revenue analysis for 2012 and 2013, as well as the forecast up to 2022. Global Vaccine Market, by Technology Class Live Toxoid Conjugate Sub-Unit Recombinant Vector Vaccines DNA Vaccines Synthetic Vaccines Dentritic Vaccines Global Vaccine Market, by Types Preventive Therapeutic Global Vaccine Market, by End Users Pediatric Adult Global Vaccine Market, by Disease Indication Infectious Diseases Cancer Allergies Others Global Vaccine Market, by Geography North America Europe Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Asia-Pacific Rest of the World (RoW)
Other industries we cover: • • • • • • • • •
Advertising and Media Automotive and Parts Consumer Goods Healthcare and Medical Finance and Banking Food and Beverages Travel and Tourism Textiles and Clothing SWOT Analysis
Table of Content 1 Introduction (Page No. - 19) 1.1 Key Take-Aways 1.2 Report Scope 1.3 Report Segmentation 1.4 Research Methodology 1.5 Key Data Points From Secondary And Primary Sources 1.6 Logical Assumptions In This Study Based On Reliable Sources 2 Summary (Page No. - 26) 3 Technology Snapshot (Page No. - 31) 3.1 Technology Introduction 3.2 Technology Evolution 3.3 Technology Segmentation 3.4 Technology Trends By Class 3.4.1 Adjuvants 3.5 Key Vaccine Products In The Market 3.6 Technology Roadmap 4 Vaccine Research Portfolio (Page No. - 42) 4.1 Global Research Portfolio Research And Development Network 4.2 Emerging Approaches To Vaccine Developments Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
4.3 Key Research Centres 5 Value Chain Analysis (Page No. - 47) 5.1 Overview 5.2 Cold Chain Management 5.3 Key Stakeholders 5.4 Gap Analysis 5.5 Porters Five Force Analysis 6 Market Landscape (Page No. - 57) 6.1 Global Vaccine Technologies Market, Global Forecasts (2013 2022) 6.1.1 Global Vaccine Technologies Market, By Geography, 2012 2022 6.1.2 Vaccine Technologies Market Segmentation 6.1.3 Market Dynamics 6.1.3.1 Drivers 6.1.3.2 Restraints 6.1.3.3 Opportunities, Threats And Challenges 6.2 Global Vaccine Technologies Market, By End-User, 2012-2022 6.2.1 Global Vaccine Technologies Market Share, By End-User, 2012 2022 6.2.2 Paedriatic Vaccine Market, By Geography 6.2.3 Global Paedriatic Vaccine Market Share, By Geography 6.2.4 Global Adult Vaccine Market, By Geography 6.2.5 Global Adult Vaccine Market Share, By Geography 6.3 Global Vaccine Technologies Market, By Type, 2012-2022 6.3.1 Global Vaccine Technologies Market Share, By Type, 2012-2022 6.3.2 Global Preventive Vaccine Market, By Geography, 2012 2022 6.3.3 Global Preventive Vaccine Market Share, By Geography, 2012-2022 6.3.4 Global Therapeutic Vaccine Market, By Geography, 2012 2022 6.3.5 Global Therapeutic Vaccine Market Share, By Geography, 2012 2022 6.4 Global Vaccine Technologies Market, By Class, 2012 2022 6.4.1 Global Vaccine Technologies Market Share, By Class, 2012-2022 6.4.2 Live/Attenuated Vaccine Market, By Geography 6.4.2.1 Live/ Attenuated Vaccine Market Share, By Geography 6.4.3 Toxoid Vaccine Market, By Geography 6.4.3.1 Toxoid Vaccine Market Share, By Geography 6.4.4 Conjugate Vaccine Market, By Geography 6.4.4.1 Conjugate Vaccine Market Share, By Geography 6.4.5 Sub-Unit Vaccine Market, By Geography 6.4.6 Recombinant Vector Vaccine Market, By Geography, 2012 2022 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
6.4.7 Dna Vaccine Market, By Geography, 2012 2022 6.4.8 Synthetic Vaccine Market, By Geography, 2012 2022 6.4.8.1 Synthetic Vaccine Market Share, By Geography, 2012 2022 6.4.9 Dentritic Vaccine Market, By Geography, 2012 2022 6.5 Vaccine Market, By Disease Indication (2012 - 2022) 6.5.1 Infectious Disease Vaccine Market, By Geography 6.5.2 Cancer Vaccine Market, By Geography 6.5.3 Allergy Vaccine Market, By Geography 6.5.4 Others Vaccine Market, By Geography, 2012 2022 6.5.5 Others Potential Market, By Geography, 2016 2022 7 Technology Adoption (Page No. - 110) 7.1 Factors That Drive Adoption Of Vaccine Technologies (Demand And Supply Side Analysis) 7.2 North America U.S. & Canada 7.3 Europe U.K, Germany, France, Italy 7.4 Asia China, India 7.5 RoW Australia & Africa 8 Investment Analysis (Page No. - 122) 8.1 Investor Network 8.2 Investment Funding Analysis 8.3 Top Funding Organizations 9 Competitive Landscape (Page No. - 126) 9.1 Competitive Landscape Analysis Overview 9.2 Key Acquisitions/Partnerships/Agreements/Collaborations (2012 2013) 9.3 Vaccine Candidates In Pipeline Allergy 9.4 Vaccine Candidates In Pipeline Cancer 9.5 Vaccine Candidates In Pipeline Infectious Diseases 9.6 Vaccine Candidates In Pipeline Others 10 Regulatory Landscape (Page No. - 135) 10.1 Regulatory Landscape Overview 10.2 Regulations Geographic 11 Patent Analysis (Page No. - 140) 11.1 Patent Analysis Overview 11.2 Patent Analysis By Company Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
12 Analyst Recommendations (Page No. - 143) 12.1 Introduction 12.2 Technology Management Strategies 14 Appendix (Page No. - 177) Inter-Country Comparison Of Mortality For Selected Cause Of Death List of Tables Table 1 Vaccine Technologies Market, By Geography, 2012 2022 ($Billion) Table 2 Global Vaccine Technologies Market, By End-User, 2012 2022 ($Billion) Table 3 Paedriatic Vaccine Market, By Geography, 2012 2022 ($Billion) Table 4 Adult Vaccine Market, By Geography, 2012 2022 ($Billion) Table 5 Global Vaccine Technologies Market, By Type, 2012 2022 ($Billion) Table 6 Global Preventive Vaccine Market, By Geography, 2012 2022 ( $Billion) Table 7 Therapeutic Vaccine Market, By Geography, 2012 2022 ($Billion) Table 8 Global Vaccine Technologies Market, By Technology Class, 2012 2022 ($Billion) Table 9 Global Live Vaccine Market, By Geography, 2012-2022 ($Billion) Table 10 Toxoid Vaccine Market, By Geography, 2012 2022 ($Billion) Table 11 Conjugate Vaccine Market, By Geography, 2012 2022 ($Billion) Table 12 Subunit Vaccine Market, By Geography, 2012 2022 ($Billion) Table 13 Recombinant Vector Vaccine Market, By Geography, 2012 2022 ($Billion) Table 14 Dna Vaccine Market, By Geography, 2012 2022 ($Billion) Table 15 Synthetic Vaccine Market, By Geography, 2012 2022 Table 16 Dentritic Vaccine Market, By Geography, 2017 2022 ($Billion) Table 17 Global Vaccine Market, By Disease Indication, 2012 2022 ($Billion) Table 18 Infectious Disease Vaccine Market, By Geography, 2012 2022 ($Billion) Table 19 Cancer Vaccine Market, By Geography, 2012 2022 ($Billion) Table 20 Allergy Vaccine Market, By Geography, 2012 2022 ($Billion) Table 21 Others (Cardiovascular Disease, Diabetes, Smoke Cessation) Potential Market,By Geography, 2016 2022 ($Billion) Table 22 Revenue Of Top 5 Companies List of Figures Figure 1 Global Vaccine Market, 2007 2012 ($Billion) Figure 2 Global Vaccine Technologies Market,2012 2022 ($Billion) Figure 3 Porters Value Chain Analysis Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Figure 4 Global Vaccine Market, 2007 2012 ($Billion) Figure 5 Global Vaccine Technologies Market, 2013 2022 ($Billion) Figure 6 Vaccine Technologies Market, By Geography, 2012 2022 ($Billion) Figure 7 Vaccine Technologies Market Share, By Geography, 2012 2022 Figure 8 Global Vaccine Technologies Market, By End-User, 2012 2022 ($Billion) Figure 9 Global Vaccine Technologies Market Share, By End-User, 2012 2022 Figure 10 Paedriatic Vaccine Market, By Geography, 2012 2022 Figure 11 Paedriatic Vaccine Market Share, By Geography, 2012 2022 Figure 12 Adult Vaccine Market, By Geography, 2012 2022 Figure 13 Adult Vaccine Market Share, By Geography, 2012 2022 Figure 14 Global Vaccine Technologies Market, By Type, 2012 2022 Figure 15 Global Vaccine Technologies Market Share, By Type, 2012 2022 Figure 16 Preventive Vaccine Market, By Geography, 2012 2022 Figure 17 Preventive Vaccine Market Share, By Geography, 2012 2022 Figure 18 Therapeutic Vaccine Market, By Geography, 2012 2022 Figure19 Therapeutic Vaccine Market Share, By Geography, 2012 2022 Figure 20 Global Vaccine Technologies Market, By Technology Class, 2012 2022 ($Billion) Figure 21 Global Vaccine Technologies Market Share, By Class, 2012 - 2022 Figure 22 Live/Attenuated Vaccine Market, By Geography, 2012 2022 Figure 23 Live/Attenuated Vaccine Market Share, By Geography, 2012 2022 Figure 24 Toxoid Vaccine Market, By Geography, 2012 2022 Figure 25 Toxoid Vaccine Market Share, By Geography, 2012 2022 Figure 26 Conjugate Vaccine Market, By Geography, 2012 2022 Figure 27 Conjugate Vaccine Market Share, By Geography, 2012 2022 Figure 28 Subunit Vaccine Market, By Geography, 2012 2022 ($Billion) Figure 29 Sub-Unit Vaccine Market, By Geography, 2012 2022 Figure 30 Recombinant Vector Vaccine Market, By Geography, 2012-2022 Figure 31 Recombinant Vector Vaccine Market Share, By Geography, 2012 2022 Figure 32 Dna Vaccine Market, By Geography, 2012 2022 ($Billion) Figure 33 Dna Vaccine Market, By Geography, 2012 2022 Figure 34 Synthetic Vaccine Market, By Geography, 2012 2022 Figure 35 Synthetic Vaccine Market Share, By Geography, 2012 2022 Figure 36 Dentritic Vaccines, By Geography, 2012 2022 Figure 37 Dentritic Vaccine Market Share, By Geography, 2012 2022 Figure 38 Global Vaccine Market, By Disease Indication, 2012 2022 Figure 39 Global Vaccine Market Share, By Disease Indication, 2012 2022 Figure 40 Infectious Disease Vaccine Market, By Geography, 2012 2022 Figure 41 Infectious Disease Vaccine Market Share, By Geography, 2012 2022 Figure 42 Cancer Vaccine Market, By Geography, 2012 2022 ($Billion) Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Figure 43 Cancer Vaccine Market, By Geography, 2012 2022 Figure 44 Allergy Vaccine Market, By Geography, 2012 2022 Figure 45 Allergy Vaccine Market Share, By Geography, 2012 2022 Figure 46 Others (Cardiovascular Disease, Diabetes, Smoke Cessation) Potential Market,By Geography, 2016 2022 ($Billion) Figure 47 Others (Cardiovascular Disease, Diabetes, Smoke Cessation) Potential Market,By Geography, 2016 2022 Figure 48 Global Vaccine Technologies Market,By Geography, 2012 2022 Figure 49 Vaccine- Investor Network Figure 50 Global Vaccine Market Share,By Key Player, 2013 Figure 51 Regulatory Approval Process Figure 52 Total Patents Filed Between 2008 2013 Figure 53 Patent Analysis By Companies (2008 2012) Related reports: Allergy Drugs Markets in China Arthritis Treatment Drugs Markets in China Healthcare and Medical Market Research
About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is one-stop-shop for all information related to market research for any sector of the industry. Along with providing in-depth analysis though reports, JSB market research also provides regular updates of the market though newsletters. Our reports are a well-researched work of market researchers with an extensive knowledge and a good level of market experience. To know more Vaccine Market - By Technology & Types, Trend Analysis By Various Classes Live / Attenuated, Subunit, Toxoid, Conjugate, DNA, Recombinant Vector, Synthetic, Dentritic Vaccines And By Indications - Infectious Diseases, Cancer, Allergy, Diabetes, Cardiovascular Disease With Market Landscape Analysis - Global Forecasts To 2022 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
http://www.jsbmarketresearch.com/healthcare-medical/r-Vaccine-Market-By-TechnologyTypes-Trend-Analysis-By-Various-Classes-Global-Forecasts-114172
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/